Marco Enea
Marco Enea
University of Palermo - Dipartimento di Scienze Economiche, Aziendali e Statistiche
Verified email at unipa.it
TitleCited byYear
Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data
F Salerno, C Cammā, M Enea, M Rössle, F Wong
Gastroenterology 133 (3), 825-834, 2007
4552007
A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
G Cabibbo, M Enea, M Attanasio, J Bruix, A Craxė, C Cammā
Hepatology 51 (4), 1274-1283, 2010
3002010
Cost‐effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
C Cammā, S Petta, M Enea, R Bruno, F Bronte, V Capursi, A Cicchetti, ...
Hepatology 56 (3), 850-860, 2012
1352012
The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data
F Fiorica, F Cartei, M Enea, A Licata, G Cabibbo, B Carau, A Liboni, ...
Cancer treatment reviews 33 (8), 729-740, 2007
1342007
Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C
S Petta, G Cabibbo, M Enea, FS Macaluso, A Plaia, R Bruno, A Gasbarrini, ...
Hepatology 59 (5), 1692-1705, 2014
892014
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems
C Cammā, VD Marco, G Cabibbo, F Latteri, L Sandonato, P Parisi, ...
Alimentary pharmacology & therapeutics 28 (1), 62-75, 2008
882008
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
E Villa, R Critelli, B Lei, G Marzocchi, C Cammā, G Giannelli, P Pontisso, ...
Gut 65 (5), 861-869, 2016
812016
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease
S Renna, C Cammā, I Modesto, G Cabibbo, D Scimeca, G Civitavecchia, ...
Gastroenterology 135 (5), 1500-1509, 2008
802008
Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
C Cammā, G Cabibbo, S Petta, M Enea, M Iavarone, A Grieco, ...
Hepatology 57 (3), 1046-1054, 2013
772013
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data
F Fiorica, F Cartei, A Licata, M Enea, S Ursino, C Colosimo, C Cammā
Cancer treatment reviews 36 (7), 539-549, 2010
592010
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation
G Cabibbo, C Genco, V Di Marco, M Barbara, M Enea, P Parisi, ...
Alimentary pharmacology & therapeutics 34 (2), 196-204, 2011
522011
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C
C Cammā, S Petta, G Cabibbo, M Ruggeri, M Enea, R Bruno, V Capursi, ...
Journal of hepatology 59 (4), 658-666, 2013
472013
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy
V Calvaruso, C Camma, V Di Marco, S Maimone, F Bronte, M Enea, ...
Journal of viral hepatitis 17 (7), 469-474, 2010
462010
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis
C Cammā, G Cabibbo, F Bronte, M Enea, A Licata, M Attanasio, ...
Journal of hepatology 51 (4), 675-681, 2009
282009
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis
S Petta, C Camma, V Di Marco, V Calvaruso, M Enea, F Bronte, G Butera, ...
Alimentary pharmacology & therapeutics 30 (6), 603-613, 2009
222009
Impact of virus eradication in patients with compensated hepatitis C virus‐related cirrhosis: competing risks and multistate model
S Petta, V Di Marco, S Bruno, M Enea, V Calvaruso, V Boccaccio, S Rossi, ...
Liver International 36 (12), 1765-1773, 2016
212016
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
S Petta, G Cabibbo, M Enea, FS Macaluso, A Plaia, R Bruno, A Gasbarrini, ...
Digestive and Liver Disease 46 (10), 936-942, 2014
202014
Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis
A Mancuso, A Mazzola, G Cabibbo, G Perricone, M Enea, A Galvano, ...
Digestive and Liver Disease 47 (4), 324-330, 2015
152015
Peginterferon‐Α_2B plus ribavirin is more effective than peginterferon‐Α_2A plus ribavirin in menopausal women with chronic hepatitis C
E Villa, C Cammā, A Di Leo, A Karampatou, M Enea, S Gitto, ...
Journal of viral hepatitis 19 (9), 640-649, 2012
122012
Centile estimation for a proportion response variable
A Hossain, R Rigby, M Stasinopoulos, M Enea
Statistics in medicine 35 (6), 895-904, 2016
102016
The system can't perform the operation now. Try again later.
Articles 1–20